D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and ...

To manage this workload, team members used custom-built generative artificial intelligence tools to help them plan the ...

"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.

Roughly a year ago Meta and IBM launched the AI Alliance, founded with 56 other organizations to advocate for an open AI ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...

Operator: Good day, and welcome to the Eve Holding, Inc. Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions ...

Q3 2025 Earnings Call Transcript March 10, 2025 Oracle Corporation misses on earnings expectations. Reported EPS is $1.47 EPS ...

In 30-plus years as a researcher, Greg Matera has never seen this ... Tick expert Rafael Vieira, assistant professor of One ...

John Conyers—the longest-serving African-American member of Congress in history—first introduced the “Commission to Study and Develop Reparation Proposals for the African-Americans Act,” or United ...

State of Michigan Retirement System lessened its position in shares of Qualys, Inc. (NASDAQ:QLYS – Free Report) by 1.1% in the 4th quarter, according to the company in its most recent 13F filing with ...

Mutual of America Capital Management LLC lessened its position in shares of Qualys, Inc. (NASDAQ:QLYS – Free Report) by 2.9% in the 4th quarter, according to the company in its most recent 13F filing ...